Shanghai HeartCare Medical Technology (HKSE:06609) Total Stockholders Equity : HK$1,176.5 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology Total Stockholders Equity?

Shanghai HeartCare Medical Technology's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,176.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shanghai HeartCare Medical Technology's Book Value per Share for the quarter that ended in Dec. 2023 was HK$30.30. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shanghai HeartCare Medical Technology's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.03.

Shanghai HeartCare Medical Technology Total Stockholders Equity Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology Total Stockholders Equity Chart

Shanghai HeartCare Medical Technology Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

90.21

807.72

1,680.64

1,301.51

1,176.52

Shanghai HeartCare Medical Technology Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial				1,680.64	1,518.50	1,301.51	1,222.33	1,176.52

Shanghai HeartCare Medical Technology (HKSE:06609) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shanghai HeartCare Medical Technology's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1176.517	-	0)	/	38.8344
	=	30.30

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shanghai HeartCare Medical Technology's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.372	+	34.423)	/	1176.517
	=	0.03

Shanghai HeartCare Medical Technology Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN

Website

http://www.strokemedical.com

Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.

Executives

Ding Kui	2201 Interest of corporation controlled by you
Wisary Limited	2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines